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Abstract
Purpose There is an ongoing debate on whether or not to use oral antibiotic bowel decontamination in colorectal surgery, despite
the numerous different regimens in terms of antibiotic substances and duration of application. As we routinely use oral antibiotic
bowel decontamination (selective decontamination of the digestive tract (SDD) regimen and SDD regimen plus vancomycin
since 2016) in surgery for diverticular disease, our aim was to retrospectively analyze the perioperative outcome in two inde-
pendent centers.
Methods Data from two centers with a routine use of oral antibiotic bowel decontamination for up to 20 years of experience were
analyzed for the perioperative outcome of 384 patients undergoing surgery for diverticular disease.
Results Overall morbidity was 12.8%, overall mortality was 0.3%, the overall rate of anastomotic leakage (AL) was 1.0%, and
surgical site infections (SSIs) were 5.5% and 7.8% of all infectious complications including urinary tract infections and pneu-
monia. No serious adverse events were related to use of oral antibiotic bowel decontamination. Most of the patients (93.8%)
completed the perioperative regimen. Additional use of vancomycin to the SDD regimen did not show a further reduction of
infectious complications, including SSI and AL.
Conclusion Oral antibiotic decontamination appears to be safe and effective with low rates of AL and infectious complications in
surgery for diverticular disease.
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Introduction
Diverticular disease is a common burden in western world
with increasing incidence over the past decades [1, 2].
Despite growing prevalence of asymptomatic diverticulosis
with increasing age, only about 20% of affected people suffer
from diverticulitis [1, 3]. In cases of chronic recurrent, acute,
or chronic complicated cases, urgent or elective surgery can be
necessary, not only to control a septic focus like abscess or
fistula but also to avoid recurrence [1–4]. Laparoscopic tech-
nique and enhanced recovery protocols changed the perioper-
ative management substantially, not only in elective but also
in urgent or emergency cases [2, 5]. Yet treatment and espe-
cially surgical intervention for symptomatic diverticular dis-
ease should follow current guidelines [1, 2, 6–10], but there is
some discrepancy between the 2018 expired German national
guidelines and the recently published ASCRS and ESCP
guidelines. Especially the indication for surgery in diverticular
disease changed over the past years, but despite different op-
tions for classification of diverticular disease, the surgical in-
dication should primarily depend on the risk for recurrence or
a complicated course based on disease severity, which in
Germany nowadays is classified according to the
“Classification of Diverticular Disease” (CDD) [8–10].
Nevertheless, in elective surgery for diverticular disease, there
is a relevant risk for surgical and nonsurgical complications
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even in the era of laparoscopic surgery and enhanced recovery
concepts [5, 11–13].
In elective colorectal surgery, the concept of “selective de-
contamination of the digestive tract” (SDD)with use of topical
antibiotics is current subject of debate among colorectal sur-
geons [14–17]. The role of bacteria in the development of
anastomotic leakage (AL) and surgical site infections (SSIs)
has been clarified over the past years, and the use of oral
antibiotic bowel decontamination (OABD) [18–21] and com-
bined OABD and mechanical bowel preparation (MBP) is
widely recommended in elective colorectal surgery [14, 15,
22–24]. Despite that recommendation, especially in Europe,
there is no widespread use of OABD regimens but an ongoing
debate of its efficacy for prevention of AL and decreasing SSI
or infectious complications in general [15]. Data from recent
published randomized controlled trials are inconsistent due to
essential differences in OABD regimens [18, 25–27].
Up to now, there are no studies concerning the use of
OABD or antibiotic bowel decontamination in surgery for
diverticular disease. Only a few cases of sigmoid resections
are included in some of the randomized controlled trials, but
they were not separately analyzed due to the small sample
sizes [25, 27].
Based on the modified SDD regimen introduced by
Schardey et al. in gastric and rectal cancer surgery [18, 28],
the perioperative OABD has been used in colorectal surgery at
the Surgical Department of Agatharied Hospital (AH) since
1999 [17] and was successfully introduced at the Surgical
Department of Neumarkt Hospital (NH) as well.
Our aim is to analyze the safety and efficacy of routine use
of an OABD regimen with regard to infectious complications
like AL and SSI and adverse events related to medication in
surgery for diverticular disease in two regional hospitals.
Patients and Methods
Patients
We performed a bicentric retrospective cohort study in two
regional hospitals. The study was approved by the local re-
view board. All elective procedures of open and mainly lapa-
roscopic sigmoid colon resections for symptomatic or compli-
cated diverticulitis using OABD based on prospectively col-
lected data from the hospitals’ databases were analyzed. A
total of n = 384 resections was performed, thereof 332 be-
tween 1999 and 2019 in AH and n = 52 between 2017 and
2019 in NH. Indication for sigmoid colonic resections in
Germany were based in the past on Hansen and Stock classi-
fication, later on CDD classification [8, 29] and the German
national guidelines [8]. According to current recommenda-
tions, surgery was performed electively in a noninflammatory
state if possible, at least 4–6 weeks after the last episode of
diverticulitis [1, 2, 8]. Only patients with primary anastomosis
on treatment with OABD, who started the antibiotic regimen
on the day before surgery, were included in this analysis.
OABD protocol
The OABD regimen consisted of polymyxin B (100 mg),
gentamicin (80 mg), and amphotericin B (500 mg) in n =
253 patients from AH between 1999 and 2015 (PG regimen);
from 2016 to 2019 in both hospitals, a regimen consisting of
PG plus vancomycin (125 mg) was used in n = 79 (AH) and n
= 52 (NH) cases (PGV regimen) [18, 28]. OABD was admin-
istered orally in the majority of cases from the day before
surgery until the 7th postoperative day, a total of 30 dosages
per patient. The total costs for the OABD were EUR 105.60.-
for PG and EUR 335.70.- for PGV regimen (3.52 Euro/11.19
Euro per dosage). In patients receiving a protective loop
ileostomy, a Foley catheter was placed transanally during sur-
gical procedure for the topical application of the OABD.
Bowel preparation and perioperative management followed
the principles of the enhanced recovery regimen using only
a mild laxative (e.g., Prepacol®, Guerbet GmbH, Germany).
No MBP was performed. For the details of perioperative reg-
imen, see Table 1. A systemic antibiotic prophylaxis was ad-
ministered just before surgery according to WHO guidelines
[22] and evidence [30]. Only in few cases with local septic
focus, mostly in urgent surgical cases, a prolonged systemic
antibiotic therapy was administered (< 5%).
Surgical technique
The surgical procedures were performed according to the cur-
rent technical standards of open and laparoscopic procedures
by overall eight experienced colorectal surgeons (3 NH and 5
AH). The colon was divided in the upper third of the rectum
with a linear stapler (Contour linear stapler Ethicon Endo-
Surgery, Johnson and Johnson, USA). A circular double row
stapler (ILS Circular Stapler, Ethicon Endo-Surgery, Johnson
and Johnson, USA) was used for creating the anastomoses in
both hospitals applying the double-stapling technique.
Routinely, a leak test was performed using a methylene-blue
solution, air, or intraoperative rectoscopy. Urgent surgery was
defined as either a delayed emergency surgery for acute com-
plicated diverticular disease/diverticular bleeding or as an ear-
ly elective surgery because of failure of conservative therapy
with the possibility for preoperative OABD starting the eve-
ning before the surgical procedure.
Data management and variables
Perioperative data were collected together with demographic
patient information in databases in both hospitals (Table 2). In
some cases, the extent of surgery had to be expanded for
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atypical liver resections, biopsy or concomitant cholecystec-
tomy, bowel resections due to involvement in the inflamma-
tory process, and quite often urogenital resections due to
entero-vaginal or entero-vesical fistulas in chronic complicat-
ed diverticular disease.
Primary outcome measure is the rate of AL; diagnosis of
AL was made by endoscopy, CT scan, or relaparotomy. Only
cases of clinically apparent AL were recorded in our study.
Furthermore, rates of SSI, pneumonia, urinary tract infections,
cardiovascular complications, overall morbidity and mortali-
ty, and any adverse events related to OABD are analyzed. All
surgical complications occurring within 30 days after surgical
procedure were classified according to the Clavien–Dindo
classification [31]. There is no control group without use of
OABD available, since OABD is standard treatment in both
centers and no elective or urgent sigmoid resections were per-
formed without OABD.
Statistical analysis
For statistical analysis SPSS Statistics 26 was used (IBM,
Armonk, USA). The prospective databases were based on
MS Excel (Microsoft Corporation, Redmond, Washington,
USA). Descriptive statistics and calculation of the mean
values were used to summarize patients’ characteristics and
perioperative data. For comparison between subgroups, we
used Kruskal–Wallis (KW) test for not normal-distributed
values and independent samples. Normal distribution of the
differences of the means was tested using the Shapiro–Wilk
test. To compare nominal or categorical data χ2 and Fisher’s
exact (FE) tests were used. P values < 0.05 were considered
statistically significant.
Results
A total of 384 patients undergoing sigmoid resection with
primary anastomosis for diverticular disease were included.
Most of the patients underwent surgery for chronic recurrent
(CDD 3B: 60.7%), chronic complicated (CDD 3C: 19.5%),
and acute complicated diverticulitis with macroabscess (CDD
2B: 14.0%). Most of the surgical procedures were performed
electively (n = 359; 93.5%), only 25 patients (6.5%) had ur-
gent procedures; 1 (0.3%) for acute diverticular bleeding, 12
Table 1 Oral antibiotic regimen




Period of time 1999–2015 2016–2019 2017–2019
Patients (n) 253 79 52
Regimen PG:
Polymyxin B (100 mg)
Gentamicin (80 mg)
Amphotericin B (500 mg)
PGV:
Polymyxin B (100 mg)
Gentamicin (80 mg)
Amphotericin B (500 mg)
Vancomycin (125 mg)
Application Day before surgery 2 PG(V) at 6 p.m.
Day of surgery 1 PG(V) at 0 a.m.–6 a.m.–(12 a.m.)–6 p.m.
POD 1–6 1 PG(V) at 0 a.m.–6 a.m.–12 a.m.–6 p.m.
AH: Agatharied Hospital; NH: Neumarkt Hospital; POD: postoperative day
Table 2 Data items included in analysis
Patient demographic data Age
Sex
ASA score
Perioperative data Diagnosis according to CDD classification
OABD regimen and completeness
Surgical technique





Time to ileostomy reversal
Perioperative complications









OABD: oral antibiotic bowel decontamination; ASA: American Society
of Anesthesiologists; CDD: Classification of Diverticular Disease.
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(3.1%) for acute complicated diverticulitis (CDD 2A/B/C)
without chance to postpone surgery, and another 12 (3.1%)
for chronic recurrent/complicated diverticulitis with failure of
conservative therapy. In only 1.0% (n = 4) of the cases, a
protective loop ileostomy was created; 93.5% of surgical pro-
cedures were started laparoscopic, only 7 (1.8%) needed con-
version to open surgery; the other 25 procedures (6.5%) were
performed in conventional open surgical technique. Mean in-
hospital stay after surgery was 8.8 days. For patient demo-
graphic data, see Table 3. All protective loop ileostomies
could be reversed within 90 days after sigmoid resection
(mean: 81.5 days).
The overall morbidity was 12.8% (n = 49). Only 1 patient
who underwent urgent surgery for diverticular bleeding suf-
fered a stroke and died in further clinical course (0.3%); no
surgical complications occurred in this case. Overall, 30 pa-
tients (7.8%) developed infectious complication such as 21
(5.5%) SSI and 4 (1.0%) AL (Table 4). All cases of AL oc-
curred in elective surgical procedures, 3 in laparoscopic cases
and 1 in a case converted to open surgery. All AL required
reoperation with discontinuity resection. In 3 of 4 cases, bowel
continuity could be restored by a mean of 151.3 days after
initial sigmoid resection. Wound hematoma occurred in
2.6% of cases. No clostridium difficile infections occurred.
In 16 of 21 cases with SSI or AL (76%) and only 2 of 10 cases
with urinary tract infection or pneumonia microbiologic anal-
ysis detected specific germs: Enterococcus species in 7 cases,
Staphylococcus species in 8 cases (only 1 case with
methicillin-resistant Staphylococcus aureus), Pseudomonas
aeruginosa in 2 cases and candida species in 2 cases, and
Escherichia coli in 1 case. Table 4 gives an overview on all
perioperative complications and their classification.
There was a substantial difference regarding the need for an
extension of surgery onto other organs, mostly the urogenital
tract due to fistulas (n = 23), between laparoscopic and open
procedures (χ2; p = 0.005). Only 7.7% of the laparoscopic
cases were associated with extension of surgery vs. 16.0%
of cases carried out in open technique and 42.9% of cases with
a need of conversion to open surgery. Furthermore, the distri-
bution of age (KW; p = 0.005), duration of postoperative in-
hospital stay (KW; p < 0.001), surgical complications in gen-
eral (χ2; p < 0.001), SSIs (χ2; p < 0.001), urinary tract infec-
tions (χ2; p < 0.001), cardiovascular complications (χ2; p =
0.009), and all infectious complications were different (χ2; p =
0.005) for each surgical technique applied (Table 5).
For the two antibiotic regimens used for OABD (PG vs.
PGV), there was no difference between groups regarding AL
(FE; p = 0.117), surgical complications (FE; p = 0.138), SSI
(χ2; p = 0.639), rate of pneumonia (FE; p = 0.185) or urinary
tract infections (FE; p = 1.0), infectious complications in gen-
eral (FE; p = 0.316), mortality (FE; p = 0.341), and duration of
perioperative application (FE; p = 1.0). Only the length of
postoperative in-hospital stay was shorter in patients who re-
ceived PGV compared to PG (KW; p = 0.024) (Table 6 and
Fig. 1).
The OABD was completed and well tolerated by most of
our patients and therefore completed until 7th postoperative
day (n = 360; 93.8%). Only 24 patients (6.3%) discontinued
the antibiotic medication prematurely for different reasons and
possible side effects; 11 (2.9%) patients had prolonged post-
operative ileus with nausea and vomiting, and another seven
(1.8%) had selective nausea after intake of medication, which
was interpreted as an intolerance; in three cases (0.8%), med-
ication was stopped by request of patients, and in two cases
(0.6%), there was diarrhea without detection of clostridium
difficile in the stool samples (Table 6). No other side effects
or allergic reactions to the OABD regimen were observed.
Discussion
Wepresent the first clinical results of the routine use of OABD
in surgery for diverticular disease with low AL, SSI, and
Table 3 Patients’ clinical characteristics
N 384
Age (years) 61.9 ± 12.2
sex (male/female) 176/208
Postoperative in-hospital stay (days) 8.8 ± 5.5
Protective ileostomy 4 (1.0%)
Time to ileostomy reversal (days) 81.5 ± 18.5
Surgical technique Open 25 (6.5%)
Laparoscopic 352 (91.7%)
Conversion 7 (1.8%)
OABD Complete 360 (93.8%)
Incomplete 24 (6.2%)





CDD classification 0 0
1 A 0
B 1 (0.3%)
2 A 11 (2.9%)
B 54 (14.1%)
C 2 (0.5%)




OABD: oral antibiotic bowel decontamination; ASA: American Society
of Anesthesiologists; CDD: Classification of Diverticular Disease
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mortality rates. Not only elective but also urgent surgical cases
with bleeding and septic abdominal conditions are included.
With these data, we also prove the feasibility of a periopera-
tive regimen of OABD in routine clinical use.
In our bicentric analysis, we found low rates of AL (1%),
SSI (5.5%), pneumonia (1%), urinary tract infections, (1.6%)
and infectious complications in general (7.8%). Under
OABD, all complication rates were low when compared to
the reported rates achieved without this prophylaxis. In recent
clinical trials and retrospective analyses in early and delayed
surgery for diverticulitis, minor and major complication rates
of about 7.5–36.0% and 2.2–9.6% are described [11, 12, 32].
Klarenbeek et al. report of SSI rates of 15.4% and AL rates of
5.8% in laparoscopic sigmoid resections [32]. A recently
published study reported an outcome of 21% for SSI and
3.1% for AL in 1737 surgical cases of diverticulitis [33]. A
retrospectively analyzed series on 168 surgical cases reported
an outcome of 6.5% for AL and 10.8% for SSI in mostly
delayed elective procedures and 15% urgent or emergency
cases [6]; another retrospective Swiss cohort reports SSI and
AL rates of 7.2% and 5.5% [34]. Overall, in the sparse avail-
able data the reported rates for SSI and AL vary between 5.2–
21.0% and 1.8–9.2%, respectively; for other infectious com-
plications like pneumonia and urinary tract infections, rates of
about 1.5–4.1% and 4.6–5.8% are reported [6, 12, 13, 32–35].
Data report a low mortality between 0% and 2.2% mostly
caused by septic complications and AL [11–13, 32–34]. We
observed a mortality of only 0.3% as one patient died without
Table 4 Perioperative
complications Morbidity 49 (12.8%)
Mortality 1 (0.3%)
SSI Superficial 18 (4.7%)
Deep 0
Organ space 3 (0.8%)
Total 21 (5.5%)




Ostomy reversal after anastomotic leakage 3/4 (75%)
Time to terminal colostomy reversal 151.3 ± 69.1 days
Wound hematoma/seroma 10 (2.9%)
Bleeding from anastomosis with interventional treatment 1 (0.3%)
Ileostomy complication with need for surgical revision 1 (0.3%)
Incisional hernia 2 (0.5%)
Pneumonia 4 (1.0%)
Urinary tract infections 6 (1.6%)
Clostridium difficile infections 0
All infectious complications 30 (7.8%)
Stroke 2 (0.5%)
Myocardial infarction 3 (0.8%)
Clavien–Dindo classification 0 334 (87.0%)
1 11 (2.9%)
2 9 (2.3%)
3 A 4 (1.0%)
B 23 (6.0%)
4 A 1 (0.3%)
B 1 (0.3%)
5 1 (0.3%)
Surgical reinterventions N patients 25
N total 58
Interventional therapy N patients 6
N total 8
SSI: surgical site infection
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Table 5 Differences between
groups for surgical technique Laparoscopic Open Conversion Total
n 352 25 7 384
Age (years) 61.3 ± 12.0 68.7 ± 13.0 64.7 ± 10.5 61.9 ± 12.2
Duration of postoperative in-hospital stay (days) 8.3 ± 4.8 13.8 ± 7.1 17.9 ± 12.2 8.8 ± 5.5
Protective ileostomy 3 (0.9%) 1 (4%) 0 4 (1.0%)
Multivisceral resections Liver 4 (1.1%) 0 0 4 (1.0%)
Bowel 3 (0.9%) 0 0 3 (0.8%)
Urogenital 17 (4.8%) 3 (12.0%) 3 (42.9%) 23 (6.0%)
Others 3 (0.9%) 1 (4%) 1 (14.3%) 4 (1.0%)
Anastomotic leakage 3 (0.9%) 0 1 (14.3%) 4 (1.0%)
Surgical complications 28 (8.0%) 3 (12%) 4 (57.1%) 35 (9.1%)
SSI Superficial 13 (3.7%) 2 (8%) 3 (42.9%) 18 (4.7%)
Deep 0 0 0 0
Organ space 2 (0.6%) 0 1 (14.3%) 3 (0.8%)
Wound hematoma/seroma 9 (2.6%) 1 (4%) 0 9 (2.5%)
Pneumonia 4 (1.1%) 0 0 4 (1.0%)
Urinary tract infection 3 (0.9%) 2 (8%) 1 (14.3%) 6 (1.6%)
Infectious complications 22 (6.3%) 4 (16%) 4 (57.1%) 30 (7.8%)
Cardiovascular complications 3 (0.9%) 2 (8%) 0 5 (1.3%)
Mortality 1 (0.3%) 0 0 1 (0.3%)
SSI: surgical site infection
Table 6 Use of OABD:
differences between groups for
OABD regimen (PG vs. PGV)
PG PGV Total
n 253 131 384
Duration of postoperative in-hospital stay (days) 9.35 ± 6.1 7.8 ± 3.8 8.8 ± 5.5
Completeness of OABD 237 (93.7%) 123 (93.9%) 360 (93.8%)
Reasons for OABD termination PostOP ileus 11 (2.9%)
Intolerance 7 (2.1%)
Patient decision 3 (0.8%)
Diarrhea 2 (0.5%)
Time to termination (mean, postoperative days) 3.3 ± 1.2
Protective ostomy 1 3 4
Surgical technique Laparoscopic 225 (88.9%) 127 (96.9%) 352 (91.7%)
Open 23 (9.1%) 2 (1.5%) 25 (6.5%)
Conversion 5 (2.0%) 2 (1.5%) 7 (1.8%)
Anastomotic leakage 1 (0.4%) 3 (2.3%) 4 (1.0%)
Surgical complications 19 (7.5%) 16 (12.2%) 35 (9.1%)
SSI Superficial 10 (3.9%) 8 (6.1%) 18 (4.7%)
Deep 0 0 0
Organ space 2 (0.8%) 1 (0.8%) 3 (0.8%)
Pneumonia 1 (0.4%) 3 (2.3%) 4 (1.0%)
Urinary tract infection 4 2 6 (1.6%)
Infectious complications 17 (6.7%) 13 (9.9) 30 (7.8%)
Clostridium difficile infections 0 0 0
Mortality 0 1 (0.8%) 1 (0.3%)
OABD: oral antibiotic bowel decontamination; PG: polymyxin B + gentamicin + amphotericin B; PGV: poly-
myxin B + gentamicin + amphotericin B + vancomycin; SSI: surgical site infection
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surgical complications due to fatal stroke after emergency
laparoscopic sigmoid resection for diverticular bleeding.
The AL rate of 1% with 3 laparoscopic and one converted
case was low. We observed a trend of more surgical compli-
cations and SSI in the small number of converted cases (n = 7)
compared to primary open and completely laparoscopically
performed sigmoid resections. There were only a few patients
in need for urgent sigmoid resections (6.5%) to treat acute or
chronic complicated diverticulitis with a higher rate of open
procedures (36%). The PG patients were treated between
1999 and 2015, whereas the PGV group was treated between
2016 and 2019. In-hospital stays shortened over the years,
which explains the shorter hospital stay of the latter group.
For the same reason, there were more patients with laparo-
scopic vs. open procedures in the PGV compared to the PG
group. But an overall high rate of 91.7% of surgical proce-
dures performed laparoscopically for diverticular disease
(88.9% PG and 98.9% in PGV group) and insofar a technical
homogenous patient collective, however, allows valid conclu-
sions from this analysis despite the time period of 20 years.
The low number of infectious complications and especially
low rates of SSI and AL in our series are consistent with other
published data using different regimens of OABD in colorec-
tal surgery [25]. Along with a decrease of SSI and AL, a better
outcome regarding postoperative ileus and mortality is report-
ed [18, 23, 30]. Schardey et al. demonstrated a fourfold de-
crease in rates of AL and nearly 50% decrease for infectious
complications in rectal cancer surgery [18]. The recently pub-
lished SELECT trial however did not show a significant re-
duction in AL (9.7% control and 6.1% in SDD group) but a
reduction of nearly 50% (26.9% to 14.9%) of all infectious
complications [25]. In a very comprehensive meta-analysis by
Rollins et al., OABD was found to be associated with a rele-
vant reduction of SSI (RR 0.51; 0.46–0.51) and AL (0.62;
0.55–0.70) in the included registry data [23]; the reduction
of AL however was not detected in the reviewed RCTs (RR
0.69; 0.43–1.11; p = 0.13) [23]. At the same time, the avail-
able studies are inconsistent in terms of the regimen of
antibiotic drugs, duration of OABD, and the type of gastroin-
testinal surgery [18, 23, 25–27, 30]. Overall, the use of topical
antibiotics based on SDD regimens [18, 24, 25, 27] was high-
ly effective in the reduction of SSI, AL, and other infectious
complications in contrast to other concepts [26]. We recently
reported on a retrospective analyzed series on patients with
rectal cancer surgery and topic antibiotic bowel decontamina-
tion with similarly low rates of AL (5.8%) and SSI (19.9%)
[17]. In summary, the available data confirm an advantage of
the use of topically applied antibiotics in colorectal surgery
compared to controls regarding infectious complications, es-
pecially SSI. The results concerning the prevention of AL are
more inconsistent but nonetheless are positive in studies,
when antibiotic regimens are used in a reasoned combination
[17, 18, 23–25, 27, 30].
There has been a growing evidence for more than 60 years
that bacteria play a central role in the pathogenesis of anasto-
motic leak. In an experimental setting, topical antibiotics were
shown to prevent AL even in the presence of severe ischemia,
while systemic antibiotics had no protective effect [36].
In recent years, Alverdy and coworkers unraveled several
of the molecular mechanisms used by some bacteria to break
down anastomotic tissue [20, 21, 37, 38]. Central to the path-
ophysiology of AL seems to be the high collagen degradation
activity of these microorganisms [37] turning on their viru-
lence with collagenase production or the activation of MMP9
or plasminogen [37, 38]. The breakdown of collagen causes
anastomoses to lose their mechanical stability and inflamma-
tion proceeds [20, 21, 37]. In experimental settings,
Enterococci, Pseudomonas, and Serratia marcescens are
pathogens associate with AL [21, 37, 38].
Therefore, the concept behind OABD is the elimination of
potentially pathogenic bacteria from the gastrointestinal tract
thereby also eliminating bacterial virulence factors [39].
Because of the apparent role of enterococci species [37, 38],
we changed our use of topical antibiotics from PG to the
originally used PGV regimen [18, 28]. In the present analysis,
most of the infections were caused by gram-positive cocci or
Fig. 1 Summary of results and
comparison of perioperative
outcome for PG and PGV OABD
regimens. OABD: oral antibiotic
bowel decontamination; PG:
polymyxin B + gentamicin +
amphotericin B; PGV: polymyxin
B + gentamicin + amphotericin B
+ vancomycin; SSI: surgical site
infection
1673Int J Colorectal Dis (2021) 36:1667–1676
Pseudomonas aeruginosa. Nevertheless, our SDD-based con-
cept of OABD with combination of gentamicin and polymyx-
in covers gram-negative pathogens twice with the exception
of proteus since polymyxin has a gap in this regard, while
gentamicin and vancomycin both covers gram-positive path-
ogens. Amphotericin B protected from fungal overgrowth.
We did not observe any negative side effects like clostridium
difficile enteritis or antibiotic resistance. SSI and AL, overall
morbidity, and mortality rates were very low in this series just
as in our previously published RCTs of gastric and rectal
surgery using this OABD regimen [17, 18]. Previous analysis
demonstrated that the use of OABD regimen is cost-effective
despite the additional costs of about 105 Euro for PG and 335
Euro for PGV regimen and could decrease the treatment costs
by about 19% in gastric cancer surgery and even 38% in rectal
cancer surgery due to the decrease of days of in-hospital stay,
days on intensive care units, and number of surgical or inter-
ventional procedures [18, 40]. According to these data and a
recently published analysis by Bordeianou et al., infectious
complications are frequent and costly complications and
therefore strategies to prevent these complications are urgently
necessary in colorectal surgery [18, 33, 40]. However, as we
were unable to demonstrate a benefit from the additional use
of vancomycin in the surgical cases presented here and taken
together with the much higher treatment costs for the PGV
compared to the PG regimen, the PG regimen without vanco-
mycin might be sufficient to relevantly decrease the rates of
infectious complications based on our data.
The use of OABD deserves a critical look especially in
times of increasing rates of multidrug-resistant germs [41].
However, the available data on the routine use of topical an-
tibiotics like SDD regimen in intensive care units only dem-
onstrate a decrease of colonization, e.g., with enterococci spe-
cies [42, 43]. Nonetheless, as the load of multidrug-resistant
germs increases, the analysis of microbiome signatures might
be favorable [20, 21, 38, 39], in order to tailor the composition
of an OABD for the individual patient. Ideal however would
be the avoidance of antibiotics altogether in the future.
Alverdy et al. already have investigated different nonantibiot-
ic, antivirulence agents to prevent AL, which should be tested
in clinical trials rather sooner than later [39].
The study is limited by its retrospective character and miss-
ing control group. Due to the retrospective character an un-
derestimation of some minor complications may be possible,
as some superficial SSI may have been occurred after hospital
discharge without readmission to the hospital. Especially for
relevant complications and major morbidity, this bias can be
assumed to be not relevant, as theymostly occur during the in-
hospital stay or patients would have been readmitted to the
regional hospitals for treatment of such complications.
Furthermore, we compare our data to some other available
retrospective or registry series, and therefore, the same bias
can be assumed in these data [6, 33, 34].
The data are obtained over a 20-year time period, and there-
fore, some issues like in-hospital stay after surgery of 8 days
may not be estimated adequate anymore. As mentioned above,
our OABD regimen ends on the 6th postoperative day, and our
present research is focusing on using less topical antibiotics
after surgery for shorter periods of time allowing for an earlier
hospital discharge. Nevertheless, other even recently published
data report of in-hospital stays about 7–13 days [6, 33, 34].
The treatment during the included period of time followed
national guidelines and evidence, but these guidelines changed
over the years, and right now, the German national guidelines for
the diagnosis and treatment of diverticular disease are expired [8].
Recently, new American and European guidelines have been
published, and as our knowledge about the risk of recurrence
and complicated course in diverticular disease further increased,
the indication for surgery has also changed over the past decade.
Therefore, there are some surgical cases included in our analysis,
whichmight not be recommended for sigmoid resections accord-
ing to these guidelines anymore [9, 10]. Besides, there are a
bunch of classifications for diverticular disease and acute diver-
ticulitis, and as none of these classifications seems to be better
validated than the others, we use the CDD classification accord-
ing to the German guidelines [8–10]. This CDD classification is
thereby based on the former used Hinchey and Hansen/Stock
classifications but additionally includes diagnostic and therapeu-
tic aspects [8]. Overall, despite these limitations, our analysis
represents surgical everyday life as our standard of care verywell.
Conclusion
According to our results, OABD seems to be an effective and
safe tool for prevention of not only AL but also SSI and other
infectious complications in the surgery of diverticular disease.
A decrease of these infectious complications in gastrointesti-
nal surgery can not only decrease additional treatment costs
but also improve our patients’ quality of life and health, which
should be the primary focus of our work as surgeons [33].
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